244 related articles for article (PubMed ID: 23673334)
1. Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.
Toteja N; Gallego JA; Saito E; Gerhard T; Winterstein A; Olfson M; Correll CU
Int J Neuropsychopharmacol; 2014 Jul; 17(7):1095-105. PubMed ID: 23673334
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.
Ayenew W; Asmamaw G; Bitew T
Int J Neuropsychopharmacol; 2021 Dec; 24(12):956-964. PubMed ID: 34245271
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
4. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
Sneider B; Pristed SG; Correll CU; Nielsen J
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
[TBL] [Abstract][Full Text] [Related]
5. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
[TBL] [Abstract][Full Text] [Related]
6. The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children.
Matone M; Localio R; Huang YS; dosReis S; Feudtner C; Rubin D
Health Serv Res; 2012 Oct; 47(5):1836-60. PubMed ID: 22946905
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country.
Armstrong KS; Temmingh H
Braz J Psychiatry; 2017; 39(4):293-301. PubMed ID: 28177063
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic use in children and adolescents: a 1-year follow-up study.
Baeza I; de la Serna E; Calvo-Escalona R; Morer A; Merchán-Naranjo J; Tapia C; Martínez-Cantarero MC; Andrés P; Alda JA; Sánchez B; Arango C; Castro-Fornieles J
J Clin Psychopharmacol; 2014 Oct; 34(5):613-9. PubMed ID: 25154009
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.
Gallego JA; Bonetti J; Zhang J; Kane JM; Correll CU
Schizophr Res; 2012 Jun; 138(1):18-28. PubMed ID: 22534420
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of antipsychotic polypharmacy in Hong Kong.
Lung SLM; Lee HME; Chen YHE; Chan KWS; Chang WC; Hui LMC
Asian J Psychiatr; 2018 Mar; 33():113-120. PubMed ID: 29574303
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.
Cotes RO; Goldsmith DR; Kopelovich SL; Lally CA; Druss BG
Community Ment Health J; 2018 Aug; 54(6):699-706. PubMed ID: 29127560
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.
Correll CU; Gallego JA
Psychiatr Clin North Am; 2012 Sep; 35(3):661-81. PubMed ID: 22929872
[TBL] [Abstract][Full Text] [Related]
15. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.
Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C
Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264
[TBL] [Abstract][Full Text] [Related]
17. Prescribing of antipsychotics in UK primary care: a cohort study.
Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
[TBL] [Abstract][Full Text] [Related]
18. A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents.
Patten SB; Waheed W; Bresee L
Can J Psychiatry; 2012 Dec; 57(12):717-21. PubMed ID: 23228229
[TBL] [Abstract][Full Text] [Related]
19. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
